Search details
1.
Bleeding Risk of Acupuncture for Patients with Hematological Malignancies Accompanying Thrombocytopenia: A Retrospective Chart Review.
J Integr Complement Med
; 30(1): 77-84, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37405736
2.
Relapse of Ulcerative Colitis with Immune Thrombocytopenia and Pyoderma Gangrenosum Subsequent to Receiving COVID-19 Vaccination.
Intern Med
; 63(5): 665-669, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-38171870
3.
Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.
Cancer Sci
; 103(2): 245-51, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22044593
4.
Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era.
Cancer
; 118(17): 4166-72, 2012 Sep 01.
Article
in English
| MEDLINE | ID: mdl-22213346
5.
Serum IgG and lymphocyte counts are useful for the early detection of infection in patients receiving bendamustine-rituximab therapy.
J Clin Exp Hematop
; 62(2): 91-98, 2022 Jun 28.
Article
in English
| MEDLINE | ID: mdl-35153257
6.
[Clinical analysis of 3 cases with primary splenic diffuse large B-cell lymphoma].
Rinsho Ketsueki
; 52(8): 703-7, 2011 Aug.
Article
in Japanese
| MEDLINE | ID: mdl-21897078
7.
MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma.
J Clin Exp Hematop
; 61(1): 22-28, 2021 Mar 18.
Article
in English
| MEDLINE | ID: mdl-33551437
8.
Femoral marrow MRI is a non-invasive, non-irradiated and useful tool for detecting bone marrow involvement in non-Hodgkin lymphoma.
J Clin Exp Hematop
; 61(2): 78-84, 2021 Jun 05.
Article
in English
| MEDLINE | ID: mdl-33551438
9.
Long-term results of dose-intensive chemotherapy with G-CSF support (TCC-NHL-91) for advanced intermediate-grade non-Hodgkin's lymphoma: a review of 59 consecutive cases treated at a single institute.
Oncol Res
; 17(3): 137-49, 2008.
Article
in English
| MEDLINE | ID: mdl-18669165
10.
The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.
Leuk Lymphoma
; 59(1): 97-104, 2018 01.
Article
in English
| MEDLINE | ID: mdl-28593796
11.
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
Gan To Kagaku Ryoho
; 34(6): 885-9, 2007 Jun.
Article
in Japanese
| MEDLINE | ID: mdl-17565251
12.
[Treatment of leukemia in senior adults].
Nihon Rinsho
; 70 Suppl 2: 737-43, 2012 Apr.
Article
in Japanese
| MEDLINE | ID: mdl-23134036
13.
Schedule-dependent interactions between pemetrexed and cisplatin in human carcinoma cell lines in vitro.
Oncol Res
; 16(2): 85-95, 2006.
Article
in English
| MEDLINE | ID: mdl-16898269
14.
Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro.
Cancer Chemother Pharmacol
; 54(6): 505-13, 2004 Dec.
Article
in English
| MEDLINE | ID: mdl-15340759
15.
Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
Leuk Lymphoma
; 48(2): 431-3, 2007 Feb.
Article
in English
| MEDLINE | ID: mdl-17325912
16.
The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
Anticancer Res
; 29(11): 4589-96, 2009 Nov.
Article
in English
| MEDLINE | ID: mdl-20032408
17.
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
Invest New Drugs
; 25(1): 31-40, 2007 Feb.
Article
in English
| MEDLINE | ID: mdl-16865529
Results
1 -
17
de 17
1
Next >
>>